BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA

    MDR report key: 7467762 · Received April 26, 2018

    Report

    Report Number
    MW5076800
    Event Type
    Death
    Date Received
    April 26, 2018
    Report Date
    April 24, 2018
    Manufacturer
    FERRING PHARMACEUTICALS
    Product Code
    MOZ
    UDI-DI
    5556410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL

    Narratives

    Description of Event or Problem · 1

    PATIENT PASSED AWAY BETWEEN (B)(6) 2018. MDO WAS NOT AWARE OF THIS PRIOR TO SCHEDULING MEDICATION. SHE DID NOT KNOW THE EXACT DAY OF DEATH. DOSE OR AMOUNT: 10 MG MILLIGRAMS. FREQUENCY: OTHER: WEEKLY FOR 3 WEEKS. ROUTE: INTRA-ARTICULAR. THERAPY START DATE: (B)(6) 2018. DIAGNOSIS OR REASON FOR USE: OSTEOARTHRITIS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    310121 EUFLEXXA HAYLURONIC ACID, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS N11704A 5556410001

    Patients

    Seq Age Sex Outcome Treatment
    1 Death